Humanoids Get the Headlines. Task-Specific Robots Are Getting the Contracts.

Every week there's a new humanoid robotics reveal. A sleek bipedal machine carrying boxes. A robot hand folding laundry. A press event with a CEO promising a million units by 2027. The hype machine is running at full tilt — and for good reason. Humanoid robots represent one of the most ambitious technological bets of the decade.

But Forbes this week published an analysis arguing that all the humanoid noise may be obscuring a quieter truth: task-specific robots are already winning the market — and may keep winning it for a long time yet.

It's a view worth taking seriously, even if you're bullish on humanoids long-term.

The Humanoid Pitch, and Why It's Compelling

The case for humanoids starts with the world we built. Factories, warehouses, offices, hospitals — they're all designed for humans. Doorknobs, staircases, steering wheels, keyboards — all assume a roughly human body operating them. A robot that can work in these spaces without retrofitting them is enormously valuable, the argument goes. Train once, deploy anywhere.

That's the pitch from companies like Figure AI, Apptronik, Agility Robotics, and Unitree. And it's not a fantasy — humanoids are genuinely getting better at dexterous manipulation, navigation, and learning from demonstration at a pace that would have seemed impossible five years ago. Figure 02 robots are already sorting packages on 17-hour shifts. BMW is running humanoid pilots on the factory floor. The technology is real.

The Task-Specific Counterargument

Here's what Forbes is pointing at: for every humanoid pilot, there are dozens of task-specific deployments that are already profitable, already scaled, and already solving real problems — quietly, without the press events.

Autonomous forklifts are navigating warehouses at companies like Amazon, Walmart, and DHL with no fanfare. Robotic welding arms have been running in automotive plants for forty years and are getting meaningfully smarter every cycle. Surgical robots — purpose-built, FDA-cleared, and limited to specific procedures — are now used in hundreds of thousands of operations a year. Agricultural robots are selectively harvesting strawberries and pruning grapevines with precision that humanoids can't yet match.

These machines don't look impressive on a conference stage. They don't go viral. But they generate revenue. And that matters, because robotics at scale is ultimately a return-on-investment story, not a science fair.

The core of the Forbes argument is this: a task-specific robot doesn't need to be generally capable. It just needs to be reliably better than a human at one thing, in one environment, at a cost that pencils out. That's a much lower bar to clear — and many robots are already clearing it.

Where Humanoids Actually Have an Edge

To be fair to the humanoid side: there are real scenarios where general-purpose capability beats specialization, and they're growing.

Unstructured environments — disaster response, household assistance, construction sites — don't lend themselves to specialized solutions. A robot that can carry debris, climb a ladder, and use a power tool is more valuable than three purpose-built robots that can each do only one of those things. Small-batch manufacturing is another humanoid stronghold. A factory running twenty different products in shifting configurations needs flexibility that static automation can't provide. Humanoids, trained on new tasks in hours rather than the weeks or months needed to retool specialized equipment, could genuinely transform those environments.

And labor economics keep shifting in humanoids' favor. As wage inflation continues in logistics, agriculture, and manufacturing — sectors that have historically resisted unionization and now struggle to find workers at any wage — the ROI of deploying any capable robot improves, even if that robot is more expensive per unit than a specialized machine.

The Honest Investment Thesis

For investors and industry watchers, the Forbes take is a useful corrective to the hype cycle. The robotics market is large enough for both humanoids and specialists to win — but the timelines are different, and confusing them is expensive.

Task-specific robots: commercial today, proven ROI, scaling now. Companies like Teradyne (Universal Robots), ABB, Fanuc, Intuitive Surgical, and Symbotic are delivering results on quarterly earnings calls. These are businesses, not promises. Humanoids: extraordinary long-term potential, still largely in pilot or pre-commercial phase. Figure, Agility, Apptronik — compelling technology, uncertain unit economics, years of hard work ahead before they're reliably profitable.

A smart portfolio probably holds both, weighted toward the proven and with a patient minority allocation to the visionary. The humanoid future may well arrive — but it will be built on the commercial foundation that task-specific robots are laying right now.

The robots you don't see on TikTok are often the ones actually changing the economy.

Source: Forbes via Google News | Further reading: Universal Robots cobots via Teradyne · ABB Robotics portfolio